Cite
MLA Citation
Russell M. Petrak et al.. “Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2.” Critical care explorations, vol. 3, 2021, pp. e0395–. http://access.bl.uk/ark:/81055/vdc_100145479167.0x000003